Get In Touch

Bladder cancer is a urologic malignancy occurring in the tissues of the urinary bladder. It is characterized by the uncontrolled, rapid growth of cells arising from the epithelial lining and can be proliferating to the muscular wall of urinary bladder. The bladder or urinary bladder is a hollow organ located in the pelvis (lower abdomen) which stores the urine drained from kidney. It is connected to the kidney by ureters, a tube like structure. Bladder cancer is ranked as the ninth most frequently diagnosed cancer. Region such as North America, Western and Southern Europe along with certain countries in Western Asia or Northern Africa have recorded highest incidence rates in men. Bladder cancer is more prevalent in men as compared to women; however, the sex ratio varied with different countries.

The exact causes for bladder cancer are not known. However, some of the risk factors such as excessive smoking, tobacco consumption, continuous exposure to radiation, chronic bladder infection, and previous cancer treatments are considered to cause bladder cancer. Bladder cancer can affect any age group; however, it is more prevalent in adults aged over 50 years. Furthermore, the observed trends and patterns worldwide reflect tobacco smoking as the prevalent cause of bladder cancer. Infection with schistosoma haematobium along with other risk factors are also the major causes of bladder cancer in selected population.

The global bladder cancer market is driven by increasing incidence of bladder cancer, leading to drug innovations for treatment and technological advancements. Bladder cancer is more common in adults aged over 50 years. Hence, increasing geriatric population also contributes to market growth. Furthermore, government initiatives, increasing awareness about bladder cancer and the available treatments, and progressive health care services with growing health care expenditure are expected to propel the global market. However, cancer being an asymptomatic disease at initial stage, needs accurate diagnosis at early stage. Inaccurate and unaffordable diagnosis could hamper the growth of the market. Increasing use of generic drugs and growing patent expirations are factors responsible for the sluggish growth of the market.

The global bladder cancer market can be segmented based on diagnosis, therapy, and region. Bladder cancer can be diagnosed by urine lab tests, cystoscopy, biopsy, and imaging test. Urine lab tests can be further divided into urinalysis, urine cytology, urine culture, and urine tumor marker test. The imaging tests segment can be further divided into intravenous pyelogram (IVP), computed tomography (CT) scan, magnetic resonance imaging (MRI) scan, and ultrasound. In terms of therapy, the market can be segmented in to chemotherapy, radiation therapy, immunotherapy, and surgery.

Geographically, the bladder cancer market can be segmented into five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America holds the major share of the global bladder cancer market. Major share of the region is attributed to the rise in incidence of bladder cancer, innovative health care solutions, advanced health care infrastructure, and increasing concern about bladder problems. Europe accounts for the second largest share of the market. The global bladder cancer market in Asia Pacific is expected to expand at a high growth rate. This rise is primarily due to growing awareness about bladder disease and innovative diagnostic and treatment options. Major players in the market find countries in Asia to be lucrative markets for bladder cancer and are making significant investments, leading to market growth.

Key players in the global bladder cancer market include AstraZeneca plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Co., F. Hoffmann-La Roche, GlaxoSmithKline plc, Novartis International AG, Pfizer Inc., and Sanofi.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Bladder Cancer Market

Pre Book